PTSM: Pharmaceutical Technology Sourcing and Management
The AIM-9000 infrared microscope contains automated analysis functions and a wide-field camera option.
On August 24, 2016, Shimadzu Scientific Instruments (SSI) announced the release of the AIM-9000 infrared microscope. With automated analysis functions and a wide-field camera option, the microscope enables analysts to observe, measure, and analyze micro samples. Laboratories can use this microscope system to perform high-sensitivity analysis in fields such as electrical/electronics, forensics, pharmaceuticals, life science, foods, and chemicals.
In addition to observing large areas up to 10x13 mm, analysts can use the wide field camera and microscope camera together to zoom and position areas as small as 30x40 μm without loss or repositioning of the sample. The microscope has a 30,000:1 signal-to-noise ratio which allows users to obtain spectra from small contaminants for library matching and identification.
The microscope also features automatic contaminant recognition and registration. The microscopes software automatically selects potential areas for analysis and suggests optimal aperture sizes and angles. The user can then select all for analysis, select none, or add their own manually with a mouse click-and-drag operation. All selected sample images are saved into the measured spectral file.
The system contains a visible/infrared dual view system. This allows users to measure infrared spectra while simultaneously checking a visible image of the sample. This provides for more confident measurements and decreases measurement time. Analysts can also use the high-speed mapping program, which captures microscope images and synthesizes them to create visual images for large areas.
Source: Shimadzu Scientific Instruments
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.